Results 81 to 90 of about 679,279 (310)

Post-Coronavirus Disease 2019 Effects in an Active University Population: A Within-Campus Cross-Sectional Study at a Major Educational Institution

open access: yesMayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective: To evaluate the associations among post-coronavirus disease 2019 (COVID-19) prevalence; risk factors and comorbidities have not been firmly established within a university outpatient population.
Marcelo Hernández-Mora, MD   +6 more
doaj   +1 more source

Infección por SARS-COV-2 en trabajadores de la salud: análisis de riesgo epidemiológico en una institución de alta complejidad de Bogotá, Colombia, 2020

open access: yesInfectio, 2022
Objective: To determine the incidence of SARS-CoV-2 infection and its association with sociodemographic, clinical, and occupational characteristics in health workers (HCWs) in the COVID-19 risk area.Material and method: Longitudinal analytical study in a
Milcíades Ibáñez-Pinilla
doaj   +1 more source

On the origins of SARS-CoV-2 [PDF]

open access: yesNature Medicine, 2021
Stakeholders in public health must lobby policy makers to make decisions based on evidence, not political expediency, particularly when the studies that hang in the balance are critical to understanding the origins of epidemics.
openaire   +2 more sources

Organizing the interface—Plasma membrane architecture and receptor dynamics in virus‐cell interactions

open access: yesFEBS Letters, EarlyView.
Plasma membranes contain dynamic nanoscale domains that organize lipids and receptors. Because viruses operate at similar scales, this architecture shapes early infection steps, including attachment, receptor engagement, and entry. Using influenza A virus and HIV‐1 as examples, we highlight how receptor nanoclusters, multivalent glycan interactions ...
Jan Schlegel, Christian Sieben
wiley   +1 more source

Expression of SARS-CoV-2 proteins from rVSVInd-SARS-CoV-2.

open access: yes, 2021
To check the expression of SARS-CoV-2 RBD, S1, SF, and E proteins from the rVSVInd-SARS-CoV-2 infected cells, BHK-21 cells were infected with the virus at an MOI of 6.
Taewoo Kim (1456888)   +30 more
core   +1 more source

Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus

open access: yesFrontiers in Immunology
Modified vaccinia virus Ankara (MVA) has been widely tested in clinical trials as recombinant vector vaccine against infectious diseases and cancers in humans and animals.
Diana Diaz-Cánova   +4 more
doaj   +1 more source

Polymorphism of SARS-CoV Genomes

open access: yesActa Genetica Sinica, 2006
In this work, severe acute respiratory syndrome associated coronavirus (SARS-CoV) genome BJ202 (AY864806) was completely sequenced. The genome was directly accessed from the stool sample of a patient in Beijing. Comparative genomics methods were used to analyze the sequence variations of 116 SARS-CoV genomes (including BJ202) available in the NCBI ...
SHANG, Lei   +6 more
openaire   +2 more sources

Biophysical approaches for studying viral entry

open access: yesFEBS Letters, EarlyView.
Viruses infect all living organisms and have been responsible for major epidemics and pandemics. Their ongoing evolutionary battle with host defenses creates a constant need for improved tools to study viral behavior. Advancing methods to probe viral attachment, fusion, and genome release deepen our understanding of how infections begin and support the
Inbar Yosibash, Raya Sorkin
wiley   +1 more source

Proyecto Argentino Interinstitucional de genómica de SARS-CoV-2. Reporte Nº 1 Inicial. “Análisis de secuencias de SARS-CoV-2 obtenidas de pacientes con COVID-19 de Argentina”

open access: yes, 2020
Hasta el 9 de septiembre 2021 el Proyecto a generado 26 Reportes. Reporte nro 1 - Análisis inicial. Reporte nro 2 – Patagonia. Reportes nro 3 y 4 - CABA y Prov. BsAs. Reporte nro 5 – Córdoba. Reporte nro 6 – Chaco. Reporte UK.
Consorcio Argentino de Genómica de SARS-CoV-2
core  

Time course of seroprevalence by neutralization assay, Elecsys® Anti-SARS-CoV-2 S, and Elecsys® Anti-SARS-CoV-2.

open access: yes, 2022
Time course of seroprevalence by neutralization assay, Elecsys® Anti-SARS-CoV-2 S, and Elecsys® Anti-SARS-CoV-2.
Satomi Takei (9538727)   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy